Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 35751-35800 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT06055205
A Pain and Coordination Plan for Reduced Opioid Use After Accidental Injuries
NARecruiting
232 participants
Started: Sep 25, 2023 · Completed: Dec 31, 2028
3 conditions3 sponsors1 location
NCT06236464
Identification of the Pathogenetic Mechanisms Underlying Squamous Cell Carcinomas
N/ARecruiting
170 participants
Started: Sep 25, 2023 · Completed: Mar 31, 2026
2 conditions1 sponsor4 locations
NCT05877157
Pain AND Opioids After Surgery
N/ARecruiting
10,000 participants
Started: Sep 25, 2023 · Completed: Sep 30, 2026
4 conditions2 sponsors4 locations
NCT06174545
Effectiveness and Safety of Pigment Solution Program (PSP) as Adjuvant Therapy in Melasma
NARecruiting
33 participants
Started: Sep 25, 2023 · Completed: Dec 31, 2023
1 condition2 sponsors1 location
NCT06074796
The Determinants of Fertility Preservation in TRANSgender Patients.
N/ARecruiting
230 participants
Started: Sep 25, 2023 · Completed: Apr 30, 2024
3 conditions1 sponsor1 location
NCT06001892
Tennessee Youth Prepared for Success
NARecruiting
1,200 participants
Started: Sep 25, 2023 · Completed: May 31, 2026
3 conditions1 sponsor1 location
NCT06389552
Long-term Observational Study to Evaluate the DFS and OS of Adjuvant FOLFIRINOX Regimen in Pancreatic Cancer Patients
N/ARecruiting
36 participants
Started: Sep 25, 2023 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT05943756
Evaluation of Well-being Interventions in Adults With TBI
NARecruiting
94 participants
Started: Sep 25, 2023 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT05428345
A Study of Vedolizumab SC Given to Adults With Moderate to Severe Ulcerative Colitis or Crohn's Disease in South Korea
N/ARecruiting
600 participants
Started: Sep 25, 2023 · Completed: Nov 30, 2027
3 conditions1 sponsor1 location
NCT06030154
Amplification of Positivity for Alcohol Use
NARecruiting
100 participants
Started: Sep 25, 2023 · Completed: Jul 31, 2026
3 conditions3 sponsors1 location
NCT06038721
Unified Protocol: Community Connections
NARecruiting
1,500 participants
Started: Sep 25, 2023 · Completed: Sep 25, 2028
4 conditions2 sponsors1 location
NCT06220435
Tumor-directed Radiation Therapy for Patients With the Highest Risk Category of Localized Prostate Cancer
NARecruiting
76 participants
Started: Sep 25, 2023 · Completed: Sep 1, 2031
1 condition1 sponsor2 locations
NCT06055491
Vitamin D3 Combined With Strengthening Exercise for Lateral Epicondylitis of Elbow
NARecruiting
100 participants
Started: Sep 25, 2023 · Completed: Feb 20, 2026
1 condition1 sponsor1 location
NCT06144554
Post Market Registry for the Omnipod 5 System in Children and Adults With Type 1 Diabetes
N/ARecruiting
2,200 participants
Started: Sep 25, 2023 · Completed: Sep 30, 2027
1 condition1 sponsor1 location
NCT06055478
Effect of Suprascapular Nerve Block and Axillary Nerve Block After Arthroscopic Rotator Cuff Repair
NARecruiting
100 participants
Started: Sep 25, 2023 · Completed: Sep 20, 2025
1 condition2 sponsors1 location
NCT06052475
Physiological Versus Right Ventricular Outcome Trial Evaluated for Bradycardia Treatment Upgrades
NARecruiting
155 participants
Started: Sep 25, 2023 · Completed: Aug 31, 2026
2 conditions1 sponsor12 locations
NCT06056089
Modified Dosage for Moderate Acute Malnutrition (MODAM-MAM)
NARecruiting
2,400 participants
Started: Sep 25, 2023 · Completed: Sep 25, 2026
1 condition3 sponsors3 locations
NCT06114784
Microbiome and Host Susceptibility in Severe Pneumonia, a Prospective, Multicenter, Cohort Study
N/ARecruiting
2,000 participants
Started: Sep 25, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor15 locations
NCT05743400
Thymoglobulin® Pharmacokinetics in Patients Undergoing Hematopoietic Stem Cell Transplantation
PHASE4Recruiting
35 participants
Started: Sep 25, 2023 · Completed: Apr 25, 2025
1 condition1 sponsor2 locations
NCT05609487
Evaluation of the Safety Plan to Prevent Suicidal Reiteration
NARecruiting
2,387 participants
Started: Sep 25, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT06089109
Creating VIP Corps to Reduce Maternal Deaths
NARecruiting
2,800 participants
Started: Sep 25, 2023 · Completed: Sep 29, 2027
1 condition2 sponsors1 location
NCT05489562
Use of Intraoral Suction and Its Effects on Obstructive Sleep Apnea
NARecruiting
40 participants
Started: Sep 25, 2023 · Completed: Oct 31, 2024
1 condition2 sponsors1 location
NCT05883137
High-flow Nasal Oxygenation for Apnoeic Oxygenation During Intubation of the Critically Ill
N/ARecruiting
150 participants
Started: Sep 25, 2023 · Completed: Jun 30, 2026
4 conditions2 sponsors1 location
NCT06143553
Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection in the Treatment of Metastatic Breast Cancer
PHASE3Recruiting
168 participants
Started: Sep 25, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor3 locations
NCT06180993
Evaluation of the Effectiveness and Impact of Nirsevimab Administered as Routine Immunization
N/ARecruiting
42,000 participants
Started: Sep 25, 2023 · Completed: Oct 31, 2026
1 condition1 sponsor1 location
NCT05918367
Multicenter Ventral Mesh Rectopexy Registry Collaborative
N/ARecruiting
200 participants
Started: Sep 25, 2023 · Completed: Sep 30, 2032
6 conditions1 sponsor5 locations
NCT06159296
Effect of Inhaled Hydroxy Gas on Long COVID Symptoms
NARecruiting
25 participants
Started: Sep 25, 2023 · Completed: May 31, 2024
1 condition1 sponsor1 location
NCT06074471
Motor Sparing Supraclavicular Block
NARecruiting
44 participants
Started: Sep 25, 2023 · Completed: May 31, 2024
2 conditions1 sponsor1 location
NCT06038071
Family Mid-Upper Arm Circumference (MUAC) Follow-up After Recovery From Acute Malnutrition (MODAM-fMUAC)
NARecruiting
3,600 participants
Started: Sep 25, 2023 · Completed: Sep 25, 2026
2 conditions3 sponsors3 locations
NCT06061484
Modified Dosage for Severe Acute Malnutrition
NARecruiting
2,400 participants
Started: Sep 25, 2023 · Completed: Sep 25, 2026
1 condition3 sponsors3 locations
NCT06066307
Olfactory Performance in Culinary Arts Students
PHASE4Recruiting
120 participants
Started: Sep 25, 2023 · Completed: Nov 21, 2024
2 conditions2 sponsors1 location
NCT05980793
Denervation for Osteoarthritis in the PIP-joint Efficacy Study (DOPS)
NARecruiting
90 participants
Started: Sep 25, 2023 · Completed: Jul 15, 2029
2 conditions2 sponsors1 location
NCT05785702
Anti-wandering System for People With Intellectual Disability
NARecruiting
60 participants
Started: Sep 25, 2023 · Completed: Jan 31, 2024
1 condition3 sponsors1 location
NCT06554145
Development and Evaluation of AI Program for Predicting Bacterial Species From Urine Gram Stain Specimens
N/ARecruiting
15,000 participants
Started: Sep 25, 2023 · Completed: Aug 31, 2028
1 condition3 sponsors1 location
NCT06028451
ManagemEnt of Antifungal Drug in Invasive Aspergillosis:a Real-word Study
N/ARecruiting
550 participants
Started: Sep 25, 2023 · Completed: Dec 15, 2024
1 condition1 sponsor1 location
NCT05920382
Radiofrequency Ablation for the Treatment of Post-knee Arthroplasty Chronic Pain.
NARecruiting
86 participants
Started: Sep 25, 2023 · Completed: Dec 1, 2027
3 conditions1 sponsor1 location
NCT06120127
Postoperative Chemotherapy With/Without Radiotherapy and Immunotherapy for Colorectal Liver Metastases With High Risk of Locally Recurrence
PHASE2Recruiting
80 participants
Started: Sep 25, 2023 · Completed: Sep 25, 2025
4 conditions1 sponsor1 location
NCT06147570
A Study of HS-10365 in Patients With Advanced or Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer
PHASE2Recruiting
62 participants
Started: Sep 25, 2023 · Completed: Aug 31, 2028
1 condition1 sponsor1 location
NCT06040450
The Impact of Outdoor Sports Practice on the Well-Being of Disabled People
N/ARecruiting
500 participants
Started: Sep 25, 2023 · Completed: Dec 31, 2024
1 condition3 sponsors1 location
NCT06144905
Norwegian Microbiota Study in Anorexia Nervosa
N/ARecruiting
180 participants
Started: Sep 24, 2023 · Completed: Sep 30, 2043
5 conditions9 sponsors1 location
NCT06083727
Primary Cesarean Section in Primigravida and Muligravida in Sohag and Al Balyana Cities
N/ARecruiting
100 participants
Started: Sep 24, 2023 · Completed: Mar 24, 2024
1 condition1 sponsor1 location
NCT05356611
Engage for Late-Life Depression and Comorbid Executive Dysfunction
NARecruiting
20 participants
Started: Sep 24, 2023 · Completed: May 31, 2025
4 conditions1 sponsor1 location
NCT06051669
Comparison of iLivTouch and FibroScan for the Assessment of Liver Fibrosis and Steatosis in Adult Patients in the US
N/ARecruiting
418 participants
Started: Sep 24, 2023 · Completed: Mar 31, 2025
2 conditions6 sponsors4 locations
NCT06147986
Evaluate the Efficacy and Safety of Allogeneic Umbilical Cord Mesenchymal Stem Cells As an Add-On Treatment for Acute ST-elevation Myocardial Infarction (STEMI) Patients
PHASE2Recruiting
41 participants
Started: Sep 24, 2023 · Completed: Jun 24, 2027
1 condition1 sponsor1 location
NCT05917795
Endoscopic Sleeve Gastroplasty With Endomina® for the Treatment of Obesity in Kidney Transplant Candidates
NARecruiting
24 participants
Started: Sep 24, 2023 · Completed: Jul 1, 2027
4 conditions1 sponsor1 location
NCT05987306
A Self-compassion Focused Intervention for Internalized Weight Bias and Weight Loss
NARecruiting
60 participants
Started: Sep 24, 2023 · Completed: May 1, 2024
1 condition2 sponsors2 locations
NCT06071312
FMT in Patients With Recurrent CDI and Ulcerative Colitis: Single Infusion Versus Sequential Approach
PHASE1/PHASE2Recruiting
64 participants
Started: Sep 23, 2023 · Completed: Sep 24, 2025
2 conditions1 sponsor1 location
NCT06582160
Enhancing Uptake of Preconception Care Services in Family Practice Clinics Using a Patient Centered Screening Tool
NARecruiting
300 participants
Started: Sep 23, 2023 · Completed: Aug 31, 2025
2 conditions1 sponsor1 location
NCT06040567
Polyneuropathy, Impairments and Physical Activity - The PolyImPAct Study
N/ARecruiting
520 participants
Started: Sep 23, 2023 · Completed: Dec 31, 2026
9 conditions1 sponsor1 location
NCT05779423
Cryoablation+Ipilimumab+Nivolumab in Melanoma
PHASE2Recruiting
37 participants
Started: Sep 23, 2023 · Completed: Jan 1, 2028
2 conditions1 sponsor1 location